Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Sep
20
2021
OIG Issues Favorable Advisory Opinion on Hospital’s Warranty Program for Joint Replacement Procedures Mintz
Jul
19
2018
FDA’s New Biosimilar Action Plan Represents the Next Step for Improving Drug Competition Mintz
Sep
18
2013
Clean Energy: Don't Believe the Shakeout Hype Mintz
Nov
19
2021
About Face: Laboratory-Developed Tests for COVID-19 Now Subject to EUA Requirements Mintz
Dec
13
2013
What the Strong Initial Public Offering (IPO) Market Means for Cleantech and Renewable Energy Companies Mintz
Mar
11
2014
Energy and Environmental Law Update - March 10, 2014 Mintz
May
28
2014
Energy & Environmental Law Update - May 27, 2014 Mintz
Jan
29
2019
ML Strategies Health Care Preview - Week of January 28, 2019 Mintz
Mar
1
2019
March 2019: Where Are We Now With 340B? Mintz
Aug
12
2014
Health Care Law Update - August 11, 2014 Mintz
Oct
14
2014
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 2014 Mintz
Nov
11
2014
Special Edition Health Care Law Update - November 11, 2014 Mintz
Nov
19
2014
CPSC Focusing on Three Areas for Reduction of CPSIA Testing Burdens Mintz
Jan
3
2015
Federal Circuit Court of Appeals Delivers Another Decision on Patentability of Myriad Patents Mintz
Feb
11
2015
FTC Tastes “Sweet” Victory: The Implications of POM Wonderful for Government Practice Mintz
Nov
10
2022
Consumer Suits Against Gerber Baby Foods Dismissed Mintz
Jul
30
2019
Senate Finance Committee Passes Drug Pricing Bill Mintz
Dec
20
2022
California Legislative Update Part II: Upcoming Changes for Health Facilities Mintz
Aug
27
2019
GAO Studies Use of PBMs in Medicare Part D Mintz
Jun
30
2015
FDA Provides 11th Hour Delay of Product Tracing Requirements for Pharmacies Mintz
Sep
1
2015
FDA’s New Four-Letter Guidance on Biosimilars Mintz
Oct
11
2019
Do You Want Fries With That? Mintz
Mar
30
2023
Medical Device Developers Now Required to Incorporate Cybersecurity Plans into FDA Premarket Submissions for “Cyber” Devices Mintz
Sep
17
2015
Senators to Receive Update on Biosimilar Implementation from CDER’s Woodcock Mintz
Apr
20
2023
Nevada Proposes to Add a Whistleblower Provision to Existing Cannabis Law Mintz
May
3
2023
Senate HELP Committee Eyes Drug Pricing and PBM Regulation Beyond Federal Programs Mintz
Nov
23
2015
Congressional Hearing Examines Competition in PBM Industry Mintz
Jan
27
2020
Recap of Our Health Law and Policy Year-in-Review Posts for 2019 Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins